Ethical Complexities and Best Practices in Informed Consent Processes for Psilocybin Services: A Qualitative Study
Open Access
- 13 May 2026
- journal article
- research article
- Published by Springer Nature in Neuroethics
- Vol. 19 (2) , 21
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Oregon Health & Science University Addiction Medicine Program Development Account
- Task order through a SAMHSA Center for Substance Abuse Prevention (CSAP) Logistics, Assistance and Planning Support contract managed by Leed Management Consulting, Inc.
This publication has 36 references indexed in Scilit:
- Essentials of Informed Consent to Psychedelic MedicineJAMA Psychiatry, 2024
- Informed Consent to Psychedelic Treatment—A Work in ProgressJAMA Psychiatry, 2024
- Giving Consent to the IneffableNeuroethics, 2024
- Towards an understanding of psychedelic-induced neuroplasticityNeuropsychopharmacology, 2022
- The illusion of knowledge in the emerging field of psychedelic researchNew Ideas in Psychology, 2022
- Novel ethical and policy issues in psychiatric uses of psychedelic substancesNeuropharmacology, 2022
- Psychedelic medicine: safety and ethical concernsThe Lancet Psychiatry, 2020
- Symptom exacerbations in trauma-focused treatments: Associations with treatment outcome and non-completionBehaviour Research and Therapy, 2016
- Therapeutic misconception, misestimation, and optimism in participants enrolled in phase 1 trialsCancer, 2012
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effectsPsychopharmacology, 2011